Galectin Therapeutics Inc.

(GALT) Trade

By |

Profile

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.

Contact Information

Website: www.galectintherapeutics.com
Email: ir@galectintherapeutics.com
Main Phone: +1 678 620-3186
Address: 4960 Peachtree Industrial Boulevard
Address 2: Suite 240
State: GA
City / Town: Norcross
Country: USA
Postal Code: 30071

Issuer Information

Exchange: NSC
CEO: Harold H. Shlevin
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.00 $ 0.03 (0.60%)
Last Price 5.00 Change $ 0.03 Change % 0.60 Tick N/A
Bid 4.97 Bid Size 200.00 Ask 5.00 Ask Size 2,800.00
Open 4.97 High 5.00 Low 4.85 Prev Close 4.97
Last Trade Volume 35,111 52 Wk Hi 9.49 52 Wk Low 1.88
Market Cap 205.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,136,738.00 EPS (TTM) -0.37 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 48 56
Number of Buys 21 27
Number of Sells 27 29
Net Activity -532054 -661893
Last 10 Buys Shares
Kevin D. Freeman 1,000
Kevin D. Freeman 1,000
Marc Rubin 1,000
Kevin D. Freeman 1,000
Kevin D. Freeman 1,000
Theodore H. Zucconi 1,000
Arthur R. Greenberg 1,000
Peter G. Traber 1,000
Kevin D. Freeman 1,000
Peter G. Traber 1,000
Last 10 Sell Shares
Harold H. Shlevin 1,000
James C. Czirr 1,000
James C. Czirr 1,000
James C. Czirr 1,000
James C. Czirr 1,000
Jack W. Callicutt 1,000
Harold H. Shlevin 1,000
Jack W. Callicutt 1,000
Harold H. Shlevin 1,000
Jack W. Callicutt 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 12 12 12 12
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 8.33 8.33 8.33 8.33
Standard Deviation 3.51 3.51 3.51 3.51
Date of Most Recent Estimate 05/31/18 05/31/18 05/15/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 2 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1